Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with … S Mazloomzadeh, S Khaleghparast, B Ghadrdoost, M Mousavizadeh, ... Jama 325 (16), 1620-1630, 2021 | 676 | 2021 |
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review AH Talasaz, P Sadeghipour, H Kakavand, M Aghakouchakzadeh, ... Journal of the American College of Cardiology 77 (15), 1903-1921, 2021 | 196 | 2021 |
Intermediate-dose versus standard-dose prophylactic anticoagulation in patients with COVID-19 admitted to the intensive care unit: 90-day results from the INSPIRATION … B Bikdeli, AH Talasaz, F Rashidi, H Bakhshandeh, F Rafiee, P Rezaeifar, ... Thrombosis and haemostasis 122 (01), 131-141, 2022 | 78 | 2022 |
Cardiovascular considerations in treating patients with coronavirus disease 2019 (COVID-19) DL Dixon, BW Van Tassell, A Vecchie, A Bonaventura, AH Talasaz, ... Journal of cardiovascular pharmacology 75 (5), 359-367, 2020 | 68 | 2020 |
Atorvastatin versus placebo in patients with covid-19 in intensive care: randomized controlled trial INSPIRATION-S Investigators bmj 376, 2022 | 65 | 2022 |
Cardiovascular complications of COVID-19: pharmacotherapy perspective AH Talasaz, H Kakavand, B Van Tassell, M Aghakouchakzadeh, ... Cardiovascular drugs and therapy 35, 249-259, 2021 | 57 | 2021 |
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review AH Talasaz, P Sadeghipour, M Aghakouchakzadeh, I Dreyfus, ... Journal of the American College of Cardiology 78 (16), 1635-1654, 2021 | 53 | 2021 |
Pharmacologic prevention of myocardial ischemia–reperfusion injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention H Kakavand, M Aghakouchakzadeh, JC Coons, AH Talasaz Journal of cardiovascular pharmacology 77 (4), 430-449, 2021 | 16 | 2021 |
Use of novel antithrombotic agents for COVID‐19: Systematic summary of ongoing randomized controlled trials AH Talasaz, P Sadeghipour, M Aghakouchakzadeh, H Kakavand, ... Journal of Thrombosis and Haemostasis 19 (12), 3080-3089, 2021 | 12 | 2021 |
Preprocedural colchicine in patients with acute ST-elevation myocardial infarction undergoing percutaneous coronary intervention: a randomized controlled trial (PodCAST-PCI) SH Hosseini, AH Talasaz, M Alidoosti, M Tajdini, BW Van Tassell, ... Journal of Cardiovascular Pharmacology 80 (4), 592-599, 2022 | 8 | 2022 |
Evaluating the role of intravenous pentoxifylline administration on primary percutaneous coronary intervention success rate in patients with ST-elevation myocardial infarction … H Kakavand, S Saadatagah, M Naderian, M Aghakouchakzadeh, A Jalali, ... Naunyn-schmiedeberg's Archives of Pharmacology 396 (3), 557-565, 2023 | 4 | 2023 |
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial AH Talasaz, P Sadeghipour, H Bakhshandeh, B Sharif-Kashani, ... Thrombosis and haemostasis 123 (07), 723-733, 2023 | 2 | 2023 |
A stepwise approach to prescribing novel lipid-lowering medications H Kakavand, M Aghakouchakzadeh, A Shahi, SS Virani, DL Dixon, ... Journal of clinical lipidology 16 (6), 822-832, 2022 | 2 | 2022 |
Optimizing antithrombotic therapy in patients with coexisting cardiovascular and gastrointestinal disease AH Talasaz, P Sadeghipour, L Ortega-Paz, H Kakavand, ... Nature Reviews Cardiology, 1-19, 2024 | 1 | 2024 |
EVALUATING THE ROLE OF INTRAVENOUS PENTOXIFYLLINE ON PRIMARY PERCUTANEOUS CORONARY INTERVENTION SUCCESS RATE IN PATIENTS WITH ST ELEVATION MYOCARDIAL INFARCTION (PENTOS-PCI) S Saadatagah, H Kakavand, M Naderian, M Aghakouchakzadeh, ... Journal of the American College of Cardiology 81 (8_Supplement), 782-782, 2023 | | 2023 |
Empagliflozin to prevent post‐operative atrial fibrillation in patients undergoing coronary artery bypass graft surgery: Rationale and design of the EMPOAF trial M Aghakouchakzadeh, K Hosseini, M Haghjoo, P Mirzabeigi, M Tajdini, ... Pacing and Clinical Electrophysiology, 0 | | |